Morfina: Paggiddiatan a nagbaetan dagiti rebision
Content deleted Content added
m r2.7.1) (robot Añadido: als:Morphin |
Xqbot (tungtungan | aramid) m r2.7.3) (Robot: Agnaynayon ckb:مۆرفین; babassit laeng a panagsukat |
||
Linia 2: | Linia 2: | ||
|- |
|- |
||
| bgcolor="#ffffff" align="center" colspan="2" | |
| bgcolor="#ffffff" align="center" colspan="2" | |
||
[[ |
[[Papeles:Morfine.png|250px|Molecular nga istruktura ti morfina]]<br /> |
||
''{{PAGENAME}}'' |
''{{PAGENAME}}'' |
||
|- |
|- |
||
| align="center" colspan="2" | ''7,8-didehydro-4,5-epoxy-<br>17-methylmorphinan-3,6-diol'' |
| align="center" colspan="2" | ''7,8-didehydro-4,5-epoxy-<br />17-methylmorphinan-3,6-diol'' |
||
|- align="center" style="border-bottom: 2px solid gray" |
|- align="center" style="border-bottom: 2px solid gray" |
||
| '''[[CAS number]]''' <br/> 57-27-2 (anhydrous) |
| '''[[CAS number]]''' <br /> 57-27-2 (anhydrous) |
||
| '''[[ATC code]]''' <br/> N02AA01 |
| '''[[ATC code]]''' <br /> N02AA01 |
||
|- |
|- |
||
| bgcolor="#eeeeee" | [[Chemical formula]] |
| bgcolor="#eeeeee" | [[Chemical formula]] |
||
Linia 26: | Linia 26: | ||
|- |
|- |
||
| bgcolor="#eeeeee" | [[Elimination half-life]] |
| bgcolor="#eeeeee" | [[Elimination half-life]] |
||
| bgcolor="#ddeeff" | |
| bgcolor="#ddeeff" | 2–3 hours |
||
|- |
|- |
||
| bgcolor="#eeeeee" | [[Excretion]] |
| bgcolor="#eeeeee" | [[Excretion]] |
||
Linia 35: | Linia 35: | ||
|- |
|- |
||
| bgcolor="#eeeeee" | [[Regulation of therapeutic goods|Legal status]] |
| bgcolor="#eeeeee" | [[Regulation of therapeutic goods|Legal status]] |
||
| bgcolor="#ddeeff" | Schedule 8 ([[Australia]]),<br>Class A ([[United Kingdom|UK]]),<br>DEA C-II ([[USA]]),<br>Schedule I ([[Canada]]) |
| bgcolor="#ddeeff" | Schedule 8 ([[Australia]]),<br />Class A ([[United Kingdom|UK]]),<br />DEA C-II ([[USA]]),<br />Schedule I ([[Canada]]) |
||
|- |
|- |
||
| bgcolor="#eeeeee" | Routes of administration |
| bgcolor="#eeeeee" | Routes of administration |
||
Linia 43: | Linia 43: | ||
| bgcolor="#ddeeff" | Extremely High |
| bgcolor="#ddeeff" | Extremely High |
||
|} |
|} |
||
Ti '''morfina''', ti principal nga aktibo nga ahente iti [[apiang]] (opio), ket maysa a nabileg nga |
Ti '''morfina''', ti principal nga aktibo nga ahente iti [[apiang]] (opio), ket maysa a nabileg nga [[opioid]] [[analgesic]] a [[droga]]. |
||
Ti balikas a "morfina" ket nagtaud iti [[Morpheus (mitolohia)|Morpheus]], ti didiosen ti [[tagainep]] iti [[mitolohia a Griego]]. |
Ti balikas a "morfina" ket nagtaud iti [[Morpheus (mitolohia)|Morpheus]], ti didiosen ti [[tagainep]] iti [[mitolohia a Griego]]. |
||
Linia 52: | Linia 52: | ||
{{stub}} |
{{stub}} |
||
[[ |
[[Kategoria:Droga]] |
||
[[als:Morphin]] |
[[als:Morphin]] |
||
Linia 64: | Linia 64: | ||
[[bs:Morfin]] |
[[bs:Morfin]] |
||
[[ca:Morfina]] |
[[ca:Morfina]] |
||
[[ckb:مۆرفین]] |
|||
[[cs:Morfin]] |
[[cs:Morfin]] |
||
[[da:Morfin]] |
[[da:Morfin]] |
Rebision manipud idi 17:35, 24 Hunio 2012
7,8-didehydro-4,5-epoxy- 17-methylmorphinan-3,6-diol | |
CAS number 57-27-2 (anhydrous) |
ATC code N02AA01 |
Chemical formula | C17H19NO3 |
SMILES | CN1CCC23C4C1Cc5c2c(c(cc5)O)OC3C(O)C=C4 |
Molecular weight | 285.4 |
Bioavailability | ~30% (oral route) |
Metabolism | renal 90%, biliary 10% |
Elimination half-life | 2–3 hours |
Excretion | renal 90%, biliary 10% |
Pregnancy category | Category C (Australia) |
Legal status | Schedule 8 (Australia), Class A (UK), DEA C-II (USA), Schedule I (Canada) |
Routes of administration | oral, SC, IM, IV |
Dependence Liability | Extremely High |
Ti morfina, ti principal nga aktibo nga ahente iti apiang (opio), ket maysa a nabileg nga opioid analgesic a droga.
Ti balikas a "morfina" ket nagtaud iti Morpheus, ti didiosen ti tagainep iti mitolohia a Griego.